BackNeuroSense Therapeutics Overview

NeuroSense Therapeutics Total Assets

Latest total assets for NRSN: $1M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$1.03M
↓ 77.53% YoYΔ $-3.55M vs prior year quarter

Peer average

Loading

NeuroSense Therapeutics Total Assets History

Loading

NeuroSense Therapeutics vs. peers: Total Assets Comparison

Loading

NeuroSense Therapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NeuroSense Therapeutics (NRSN) FAQ

NeuroSense Therapeutics posts a total assets of $1M as of December 2025. That compares with $4.6M in the prior-year period — down 77.5% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, NeuroSense Therapeutics's total assets was $4.6M. The latest reading is $1M — a 77.5% year-over-year decrease (period ending December 2025). Use the history and growth charts on this page for a longer lookback.

Total Assets is one piece of NeuroSense Therapeutics's financial statement story. At $1M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NRSN's total assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; NeuroSense Therapeutics's other metric pages and overview cover the third.